Brief: Centogene Initiates EFRONT Study To Identify Patients With Genetic Forms Of Frontotemporal Dementia
June 2 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE NV - INITIATES EFRONT STUDY TO IDENTIFY PATIENTS
WITH
GENETIC FORMS OF FRONTOTEMPORAL DEMENTIA
* CENTOGENE NV - EFRONT STUDY IS BEING CONDUCTED WITH
SUPPORT FROM
ALECTOR, INC. UNDER COMMERCIAL AGREEMENT, FINANCIAL DETAILS OF
WHICH WERE UNDISCLOSED
Source text for Eikon: ID:nGNX9CqdM1
Further company coverage: 39K.MU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice